Future directions in the treatment of ovarian cancerOZOLS, Robert F.Seminars in oncology. 2002, Vol 29, Num 1, pp 32-42, issn 0093-7754, SUP1Article

Contemporary Management of Ovarian Cancer: Insights from an Advanced Ovarian Cancer WorkshopOZOLS, Robert F.Seminars in oncology. 2000, Vol 27, Num 3, issn 0093-7754, 50 p., SUP7Conference Proceedings

Gynecologic oncologyOZOLS, Robert F.Cancer treatment and research. 1998, Vol 95, issn 0927-3042, 394 p.Serial Issue

Ovarian cancerOZOLS, Robert F.Seminars in oncology. 1998, Vol 25, Num 3, pp 255-417, issn 0093-7754Serial Issue

Second-line treatment of ovarian cancer with single-agent gemcitabineMARKMAN, Maurie.Seminars in oncology. 2002, Vol 29, Num 1, pp 9-10, issn 0093-7754, SUP1Article

The emerging role of paclitaxel in cancer chemotherapyOZOLS, Robert F.Seminars in oncology. 1995, Vol 22, Num 3, issn 0093-7754, 156 p., SUP6Conference Proceedings

The Fox Chase Cancer Center Investigators' Workshop and Consensus ConferenceOZOLS, Robert F.Seminars in oncology. 1999, Vol 26, Num 6, issn 0093-7754, 83 p., SUP18Conference Proceedings

New developments in gynecologic malignanciesOZOLS, Robert F; VERGOTE, Ignace.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, 40 p., SUP6Serial Issue

The role of gemcitabine-based doublets in the management of ovarian carcinomaTHIGPEN, Tate.Seminars in oncology. 2002, Vol 29, Num 1, pp 11-16, issn 0093-7754, SUP1Article

Prognostic factors in ovarian cancerTROPE, C.Cancer treatment and research. 1998, Vol 95, pp 287-352, issn 0927-3042Article

Weekly paclitaxel in the management of ovarian cancerMARKMAN, M.Seminars in oncology. 2000, Vol 27, Num 3, pp 37-40, issn 0093-7754, SUP7Conference Paper

Advances in the pathology of gynecologic cancerFOX, H.Cancer treatment and research. 1998, Vol 95, pp 353-376, issn 0927-3042Article

Innovative therapies for advanced ovarian cancerTRIMBLE, E. L.Seminars in oncology. 2000, Vol 27, Num 3, pp 24-30, issn 0093-7754, SUP7Conference Paper

Surgery for recurrent ovarian cancerROSE, P. G.Seminars in oncology. 2000, Vol 27, Num 3, pp 17-23, issn 0093-7754, SUP7Conference Paper

The Fox Chase Cancer Center and Free University Hospital Investigators' Workshop and Consensus Conference on PaclitaxelOZOLS, Robert F; PINEDO, Herbert.Seminars in oncology. 1999, Vol 26, Num 1, issn 0093-7754, 167 p., SUP2Conference Proceedings

Management of borderline tumors of the ovary : State of the artTROPE, C; KAERN, J.Seminars in oncology. 1998, Vol 25, Num 3, pp 372-380, issn 0093-7754Article

Ovarian germ cell tumors : An updateWILLIAMS, S. D.Seminars in oncology. 1998, Vol 25, Num 3, pp 407-413, issn 0093-7754Article

Advances in cytoreductive surgery of gynecologic cancersBENJAMIN, I; RUBIN, S. C.Cancer treatment and research. 1998, Vol 95, pp 203-217, issn 0927-3042Article

Carboplatin and paclitaxel in ovarian cancerOZOLS, R. F.Seminars in oncology. 1995, Vol 22, Num 3, pp 78-83, issn 0093-7754, SUP6Conference Paper

The role of gemcitabine in first-line treatment of advanced ovarian carcinomaTHIGPEN, Tate.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, S26-S32, SUP6Article

Three cycles versus six cycles of adjuvant paclitaxel (taxol)/carboplatin in early stage ovarian cancerYOUNG, R. C.Seminars in oncology. 2000, Vol 27, Num 3, pp 8-10, issn 0093-7754, SUP7Conference Paper

Epidemiology and risk assessment for ovarian cancerDALY, M; OBRAMS, G. I.Seminars in oncology. 1998, Vol 25, Num 3, pp 255-264, issn 0093-7754Article

Management of early ovarian cancerYOUNG, R. C; PECORELLI, S.Seminars in oncology. 1998, Vol 25, Num 3, pp 335-339, issn 0093-7754Article

Multiple cycles of high-dose chemotherapy for ovarian cancerSCHILDER, R; SHEA, T. C.Seminars in oncology. 1998, Vol 25, Num 3, pp 349-355, issn 0093-7754Article

Gemcitabine and carboplatin in second-line ovarian cancerOZOLS, Robert F.Seminars in oncology. 2005, Vol 32, Num 4, pp S4-S8, issn 0093-7754, SUP6Article